BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$7.73
0.48 (6.62%)
▲
5d:
-10.01%
30d:
-53.71%
90d:
-59.57%
WAIT
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jun 05, 2026
0d
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BNR is down 10.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BNR is down 10.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $7.73, which is considered slightly low relative to its 30-day fair value range of $7.43 to $14.27.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $6.79, while resistance sits at $10.00. The stock is showing strong short-term momentum, up 6.6% recently.
Market Sentiment: BNR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.03. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $6.79, while resistance sits at $10.00. The stock is showing strong short-term momentum, up 6.6% recently.
Market Sentiment: BNR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.03. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$7.43 -
$14.27
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.6%)
- BEARISH: Trading 47.9% above Wall St target ($4.03)
- WARNING: Recommendation downgraded due to -10.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$7.43 -
$14.27
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.79
Resistance Level
$10.00
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Wall Street Target
$4.03
(-47.9%)
Revenue Growth (YoY)
-18.9%
Profit Margin
-11.5%
Share & Embed Analysis
Last updated: June 23, 2026 8:04 AM ET
Data refreshes hourly during market hours. Next update: 9:04 AM
Data refreshes hourly during market hours. Next update: 9:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yusheng Han
BUY
314870 shares
2026-03-31
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 62 BUY |
